Collagen expression in fibroblasts with a novel LMNA mutation

Biochemical and Biophysical Research Communications

Volumn 352, Issue 3, 2007, Pages 603-608

  Nguyen, Desiree ^a   Leistritz, Dru F ^a   Turner, Lesley ^b   MacGregor, David ^b   Ohson, Kamal ^b   Dancey, Paul ^b   Martin, George M ^a   Oshima, Junko ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Aging; Collagen; Extracellular matrix; Laminopathy; Progeroid syndrome

Indexed keywords

COLLAGEN; GENE PRODUCT; PROCOLLAGEN; PROTEIN LMNA;

ADOLESCENT; ARTICLE; CASE REPORT; CELL NUCLEUS; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST CULTURE; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SPACE; LAMINOPATHY; MANDIBULOACRAL DYSPLASIA; MUTANT; MYELODYSPLASIA; PRIORITY JOURNAL; PROGERIA; SKIN; SKIN FIBROBLAST; WERNER SYNDROME;

ADOLESCENT; CELLS, CULTURED; COCKAYNE SYNDROME; COLLAGEN TYPE I; COLLAGEN TYPE III; FEMALE; FIBROBLASTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LAMIN TYPE A; LIPODYSTROPHY; MUTATION;

EID: 33845295835     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.11.070     Document Type: Article

References (36)

1. Lin F., and Worman H.J. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J. Biol. Chem. 268 (1993) 16321-16326
2. Jacob K.N., and Garg A. Laminopathies: multisystem dystrophy syndromes. Mol. Genet. Metab. 87 (2006) 289-302
3. Smith E.D., Kudlow B.A., Frock R.L., and Kennedy B.K. A-type nuclear lamins, progerias and other degenerative disorders. Mech. Ageing Dev. 126 (2005) 447-460
4. De Sandre-Giovannoli A., Chaouch M., Kozlov S., Vallat J.M., Tazir M., Kassouri N., Szepetowski P., Hammadouche T., Vandenberghe A., Stewart C.L., Grid D., and Levy N. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 70 (2002) 726-736
5. Bonne G., Di Barletta M.R., Varnous S., Becane H.M., Hammouda E.H., Merlini L., Muntoni F., Greenberg C.R., Gary F., Urtizberea J.A., Duboc D., Fardeau M., Toniolo D., and Schwartz K. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 21 (1999) 285-288
6. Fatkin D., MacRae C., Sasaki T., Wolff M.R., Porcu M., Frenneaux M., Atherton J., Vidaillet Jr. H.J., Spudich S., De Girolami U., Seidman J.G., Seidman C., Muntoni F., Muehle G., Johnson W., and McDonough B. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N. Engl. J. Med. 341 (1999) 1715-1724
7. Muchir A., Bonne G., van der Kooi A.J., van Meegen M., Baas F., Bolhuis P.A., de Visser M., and Schwartz K. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum. Mol. Genet. 9 (2000) 1453-1459
8. Cao H., and Hegele R.A. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9 (2000) 109-112
9. Novelli G., Muchir A., Sangiuolo F., Helbling-Leclerc A., D'Apice M.R., Massart C., Capon F., Sbraccia P., Federici M., Lauro R., Tudisco C., Pallotta R., Scarano G., Dallapiccola B., Merlini L., and Bonne G. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am. J. Hum. Genet. 71 (2002) 426-431
10. Chen L., Lee L., Kudlow B.A., Dos Santos H.G., Sletvold O., Shafeghati Y., Botha E.G., Garg A., Hanson N.B., Martin G.M., Mian I.S., Kennedy B.K., and Oshima J. LMNA mutations in atypical Werner's syndrome. Lancet 362 (2003) 440-445
11. Garg A., Speckman R.A., and Bowcock A.M. Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. Am. J. Med. 112 (2002) 549-555
12. Hegele R. LMNA mutation position predicts organ system involvement in laminopathies. Clin. Genet. 68 (2005) 31-34
13. Sylvius N., and Tesson F. Lamin A/C and cardiac diseases. Curr. Opin. Cardiol. 21 (2006) 159-165
14. Sebillon P., Bouchier C., Bidot L.D., Bonne G., Ahamed K., Charron P., Drouin-Garraud V., Millaire A., Desrumeaux G., Benaiche A., Charniot J.C., Schwartz K., Villard E., and Komajda M. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J. Med. Genet. 40 (2003) 560-567
15. Agarwal A.K., Fryns J.P., Auchus R.J., and Garg A. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum. Mol. Genet. 12 (2003) 1995-2001
16. De Sandre-Giovannoli A., Bernard R., Cau P., Navarro C., Amiel J., Boccaccio I., Lyonnet S., Stewart C.L., Munnich A., Le Merrer M., and Levy N. Lamin a truncation in Hutchinson-Gilford progeria. Science 300 (2003) 2055
17. Eriksson M., Brown W.T., Gordon L.B., Glynn M.W., Singer J., Scott L., Erdos M.R., Robbins C.M., Moses T.Y., Berglund P., Dutra A., Pak E., Durkin S., Csoka A.B., Boehnke M., Glover T.W., and Collins F.S. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423 (2003) 293-298
18. Fukuchi K., Katsuya T., Sugimoto K., Kuremura M., Kim H.D., Li L., and Ogihara T. LMNA mutation in a 45 year old Japanese subject with Hutchinson-Gilford progeria syndrome. J. Med. Genet. 41 (2004) e67
19. Navarro C.L., De Sandre-Giovannoli A., Bernard R., Boccaccio I., Boyer A., Genevieve D., Hadj-Rabia S., Gaudy-Marqueste C., Smitt H.S., Vabres P., Faivre L., Verloes A., Van Essen T., Flori E., Hennekam R., Beemer F.A., Laurent N., Le Merrer M., Cau P., and Levy N. Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum. Mol. Genet. 13 (2004) 2493-2503
20. Ackerman J., and Gilbert-Barness E. Hutchinson-Gilford progeria syndrome: a pathologic study. Pediatr. Pathol. Mol. Med. 21 (2002) 1-13
21. Stehbens W.E., Wakefield S.J., Gilbert-Barness E., Olson R.E., and Ackerman J. Histological and ultrastructural features of atherosclerosis in progeria. Cardiovasc. Pathol. 8 (1999) 29-39
22. Stehbens W.E., Delahunt B., Shozawa T., and Gilbert-Barness E. Smooth muscle cell depletion and collagen types in progeric arteries. Cardiovasc. Pathol. 10 (2001) 133-136
23. Ly D.H., Lockhart D.J., Lerner R.A., and Schultz P.G. Mitotic misregulation and human aging. Science 287 (2000) 2486-2492
24. Csoka A.B., English S.B., Simkevich C.P., Ginzinger D.G., Butte A.J., Schatten G.P., Rothman F.G., and Sedivy J.M. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis. Aging Cell 3 (2004) 235-243
25. Huang S., Lee L., Hanson N.B., Lenaerts C., Hoehn H., Poot M., Rubin C.D., Chen D.F., Yang C.C., Juch H., Dorn T., Spiegel R., Oral E.A., Abid M., Battisti C., Lucci-Cordisco E., Neri G., Steed E.H., Kidd A., Isley W., Showalter D., Vittone J.L., Konstantinow A., Ring J., Meyer P., Wenger S.L., von Herbay A., Wollina U., Schuelke M., Huizenga C.R., Leistritz D.F., Martin G.M., Mian I.S., and Oshima J. The spectrum of WRN mutations in Werner syndrome patients. Hum. Mutat. 27 (2006) 558-567
26. Huang S., Chen L., Libina N., Janes J., Martin G.M., Campisi J., and Oshima J. Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference. Hum. Genet. 118 (2005) 444-450
27. Korkko J., Ala-Kokko L., De Paepe A., Nuytinck L., Earley J., and Prockop D.J. Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations. Am. J. Hum. Genet. 62 (1998) 98-110
28. Schwarze U., Schievink W.I., Petty E., Jaff M.R., Babovic-Vuksanovic D., Cherry K.J., Pepin M., and Byers P.H. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV. Am. J. Hum. Genet. 69 (2001) 989-1001
29. Filesi I., Gullotta F., Lattanzi G., D'Apice M.R., Capanni C., Nardone A.M., Columbaro M., Scarano G., Mattioli E., Sabatelli P., Maraldi N.M., Biocca S., and Novelli G. Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy. Physiol. Genomics 23 (2005) 150-158
30. Varani J., Dame M.K., Rittie L., Fligiel S.E., Kang S., Fisher G.J., and Voorhees J.J. Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am. J. Pathol 168 (2006) 1861-1868
31. Jenkins G. Molecular mechanisms of skin ageing. Mech. Ageing Dev. 123 (2002) 801-810
32. Varani J., Warner R.L., Gharaee-Kermani M., Phan S.H., Kang S., Chung J.H., Wang Z.Q., Datta S.C., Fisher G.J., and Voorhees J.J. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J. Invest. Dermatol. 114 (2000) 480-486
33. West M.D. The cellular and molecular biology of skin aging. Arch. Dermatol. 130 (1994) 87-95
34. Van Berlo J.H., Voncken J.W., Kubben N., Broers J.L., Duisters R., van Leeuwen R.E., Crijns H.J., Ramaekers F.C., Hutchison C.J., and Pinto Y.M. A-type lamins are essential for TGF-beta1 induced PP2A to dephosphorylate transcription factors. Hum. Mol. Genet. 14 (2005) 2839-2849
35. Sell D.R., Lane M.A., Johnson W.A., Masoro E.J., Mock O.B., Reiser K.M., Fogarty J.F., Cutler R.G., Ingram D.K., Roth G.S., and Monnier V.M. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc. Natl. Acad. Sci. USA 93 (1996) 485-490
36. Alikhani Z., Alikhani M., Boyd C.M., Nagao K., Trackman P.C., and Graves D.T. Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J. Biol. Chem. 280 (2005) 12087-12095